SEC Form 4 · accession 0001127602-16-044535
Elevance Health, Inc. · ELV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joseph Swedish
Officer — Chair, President & CEO · Director
Period of report
Feb 29, 2016
Accepted (ET)
Mar 2, 2016 · 4:48 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001156039
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Feb 29, 2016 | S | 9,855 | $131.98 | D | 172,747 | D | |
| Common StockF3 | Feb 29, 2016 | S | 1,771 | $132.80 | D | 170,976 | D | |
| Common StockF4 | Mar 1, 2016 | A | 22,525 | $0.00 | A | 193,501 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F5 | $131.80 | Mar 1, 2016 | A | 96,388 | A | — | Mar 1, 2026 | Common Stock | 96,388 | 96,388 | D |
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 24, 2015.
- F2This transaction was executed in multiple trades at prices ranging from $131.54 to $132.53. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F3This transaction was executed in multiple trades at prices ranging from $132.55 to $133.04. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F4Represents restricted share units. Restrictions lapse as follows: 7,508 each on 3/1/17 and 3/1/18, and 7,509 on 3/1/19.
- F5The option represents a right to purchase a total of 96,388 shares, and is exercisable in six semi-annual installments, with two installments of 16,064 shares each and four installments of 16,065 shares each, beginning on September 1, 2016, which is the six-month anniversary of the option grant date.